These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29312888)

  • 1. Straightening Beta: Overdispersion of Lethal Chromosome Aberrations following Radiotherapeutic Doses Leads to Terminal Linearity in the Alpha-Beta Model.
    Shuryak I; Loucas BD; Cornforth MN
    Front Oncol; 2017; 7():318. PubMed ID: 29312888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accounting for overdispersion of lethal lesions in the linear quadratic model improves performance at both high and low radiation doses.
    Shuryak I; Cornforth MN
    Int J Radiat Biol; 2021; 97(1):50-59. PubMed ID: 32552223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some implications of linear-quadratic-linear radiation dose-response with regard to hypofractionation.
    Astrahan M
    Med Phys; 2008 Sep; 35(9):4161-72. PubMed ID: 18841869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of overdispersion of lethal lesions on cell survival curves.
    Loan M; Bhat A
    Biomed Phys Eng Express; 2022 Jun; 8(4):. PubMed ID: 35671734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The linear-quadratic model and most other common radiobiological models result in similar predictions of time-dose relationships.
    Brenner DJ; Hlatky LR; Hahnfeldt PJ; Huang Y; Sachs RK
    Radiat Res; 1998 Jul; 150(1):83-91. PubMed ID: 9650605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the LQ model with large fraction sizes results in underestimation of isoeffect doses.
    Sheu T; Molkentine J; Transtrum MK; Buchholz TA; Withers HR; Thames HD; Mason KA
    Radiother Oncol; 2013 Oct; 109(1):21-5. PubMed ID: 24060173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative analysis of radiobiological models for cell surviving fractions at high doses.
    Andisheh B; Edgren M; Belkić D; Mavroidis P; Brahme A; Lind BK
    Technol Cancer Res Treat; 2013 Apr; 12(2):183-92. PubMed ID: 23098282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extending the linear-quadratic model for large fraction doses pertinent to stereotactic radiotherapy.
    Guerrero M; Li XA
    Phys Med Biol; 2004 Oct; 49(20):4825-35. PubMed ID: 15566178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic formulation of a lineal-quadratic-linear (LQL) model: split-dose experiments and exponentially decaying sources.
    Guerrero M; Carlone M
    Med Phys; 2010 Aug; 37(8):4173-81. PubMed ID: 20879577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction.
    Brenner DJ
    Semin Radiat Oncol; 2008 Oct; 18(4):234-9. PubMed ID: 18725109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer.
    Guckenberger M; Klement RJ; Allgäuer M; Appold S; Dieckmann K; Ernst I; Ganswindt U; Holy R; Nestle U; Nevinny-Stickel M; Semrau S; Sterzing F; Wittig A; Andratschke N; Flentje M
    Radiother Oncol; 2013 Oct; 109(1):13-20. PubMed ID: 24183066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generalized Multi-Hit Model of Radiation-Induced Cell Survival with a Closed-Form Solution: An Alternative Method for Determining Isoeffect Doses in Practical Radiotherapy.
    Zhao L; Chen X; Tian J; Shang Y; Mi D; Sun Y
    Radiat Res; 2020 Apr; 193(4):359-371. PubMed ID: 32031917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compatibility of the linear-quadratic formalism and biologically effective dose concept to high-dose-per-fraction irradiation in a murine tumor.
    Otsuka S; Shibamoto Y; Iwata H; Murata R; Sugie C; Ito M; Ogino H
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1538-43. PubMed ID: 22115556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges in radiobiological modeling: can we decide between LQ and LQ-L models based on reviewed clinical NSCLC treatment outcome data?
    Santiago A; Barczyk S; Jelen U; Engenhart-Cabillic R; Wittig A
    Radiat Oncol; 2016 May; 11():67. PubMed ID: 27154064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative biological effectiveness of high linear energy transfer α-particles for the induction of DNA-double-strand breaks, chromosome aberrations and reproductive cell death in SW-1573 lung tumour cells.
    Franken NA; Hovingh S; Ten Cate R; Krawczyk P; Stap J; Hoebe R; Aten J; Barendsen GW
    Oncol Rep; 2012 Mar; 27(3):769-74. PubMed ID: 22200791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the analysis of clonogenic survival data: Statistical alternatives to the linear-quadratic model.
    Unkel S; Belka C; Lauber K
    Radiat Oncol; 2016 Jan; 11():11. PubMed ID: 26822015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-dependent Transmissibility of Chromosome Aberrations at First Mitosis after Exposure to Gamma Rays. I. Modeling and Implications Related to Risk Assessment.
    Loucas BD; Shuryak I; Kunkel SR; Cornforth MN
    Radiat Res; 2022 Apr; 197(4):376-383. PubMed ID: 35030259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiobiological evaluation of the radiation dose as used in high-precision radiotherapy: effect of prolonged delivery time and applicability of the linear-quadratic model.
    Shibamoto Y; Otsuka S; Iwata H; Sugie C; Ogino H; Tomita N
    J Radiat Res; 2012; 53(1):1-9. PubMed ID: 21997195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy.
    Park C; Papiez L; Zhang S; Story M; Timmerman RD
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):847-52. PubMed ID: 18262098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Three Radiobiological Models in Stereotactic Body Radiotherapy for Non-Small Cell Lung Cancer.
    Lu JY; Lin Z; Lin PX; Huang BT
    J Cancer; 2019; 10(19):4655-4661. PubMed ID: 31528230
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.